Hims House
✓

Hims House
Listen Score
LS 25
Global Rank
TOP 10%

इस पॉडकास्ट की जानकारी 🔗

Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week.

himshouse.substack.com
निवेश
व्यापार
होस्ट:
अद्यतन आवृत्ति:
every 9 days
औसत ऑडियो लंबाई:
51 minutes
अंग्रेज़ी
संयुक्त राज्य अमरीका
84 एपिसोड
19 सितमबर 2024
episodic
इस पॉडकास्ट कोJSONमें लाने के लिएAPIका उपयोग करें

इस पॉडकास्ट में 🔗

इन टैगों का संपादन करें

नवीनतम एपिसोड 🔗

Why payment processors treat peptides as "riskier than gambling", per gray-market peptide CEO

Why payment processors treat peptides as "riskier than gambling", per gray-market peptide CEO

Thanks to our partners: Superpower - https://superpower.com CareValidate - https://carevalidate.com FDA warning letter: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peptide-partners-llc-735063-08242026 In episode 84, Jonathan Stern talks with …
00:55:35
साझा करें
सहेजें

पिछले एपिसोड्स खोजें

Hims House के पिछले एपिसोड खोजें।
इस खोज पट्टी को अपनी वेबसाइट पर एम्बेड करें

पिछले एपिसोड

Are Peptides Coming By End Of Year?

Are Peptides Coming By End Of Year?

Thanks to our partners: Superpower - https://superpower.com CareValidate - https://carevalidate.com In episode 83, Jonathan Stern talks with Scott Brunner, CEO of the Alliance for Pharmacy Compounding, the trade group for more than 600 compounding businesses, about the WaPo report that the adminis…
00:45:33
साझा करें
सहेजें
Brazil's 2nd-largest telehealth CEO on how Hims & Hers should enter Brazil 🇧🇷

Brazil's 2nd-largest telehealth CEO on how Hims & Hers should enter Brazil 🇧🇷

Thanks to our partner: Superpower - https://superpower.com In episode 82, Jonathan Stern talks with Abrahão Fecury, co-founder and CEO of Eles & Elas, a Brazilian telehealth company built on the Hims playbook and now at about R$4.5 million (~$1 million USD) in annual revenue, growing about +10…
00:52:14
साझा करें
सहेजें
Finnrick CEO on gray market peptides, fake bodega vials, and China's manufacturing prowess

Finnrick CEO on gray market peptides, fake bodega vials, and China's manufacturing prowess

Thanks to our partner:Superpower - https://superpower.com
00:40:28
साझा करें
सहेजें
OpenLoop CEO: the peptide gray market is 2-3x bigger than analyst estimates, likely $6-8 billion

OpenLoop CEO: the peptide gray market is 2-3x bigger than analyst estimates, likely $6-8 billion

Thanks to our partner:Superpower - https://superpower.com In episode 80 of Hims House, Jonathan Stern talks with Dr. Jon Lensing, co-founder and CEO of OpenLoop, the white-label company that runs telehealth behind the scenes for other brands. Lensing started OpenLoop out of the University of Iowa's…
00:30:26
साझा करें
सहेजें
HIMS stock token hit $132 on Robinhood over the weekend due to ... $BONER coin?! 😳

HIMS stock token hit $132 on Robinhood over the weekend due to ... $BONER coin?! 😳

Thanks to our partner:Superpower - https://superpower.com 🚨 WARNING: This is not a typical Hims House podcast! I wanted to do this interview because what happened on Robinhood Chain this weekend directly affected $HIMS -- and I think Hims investors should at minimum understand what happened. Jonath…
00:39:29
साझा करें
सहेजें
🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub

🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub

Thanks to our partner:Superpower - https://superpower.com Jonathan Stern talks with Gaston Kroub, founding partner of K2K Law, registered patent attorney, and Hims House's resident legal expert on his third appearance, about the FTC's July 29 federal complaint against Hims & Hers. Kroub calls t…
00:53:59
साझा करें
सहेजें
Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro

Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro

Thanks to our partner:Superpower - https://superpower.com In episode 77, Jonathan Stern talks with Dr. Bijan Salehizadeh -- physician and managing director of NaviMed Capital, former pharma venture investor, founding investor in Auris Health. Bijan holds no position in HIMS. The conversation opens …
01:00:29
साझा करें
सहेजें
Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

Thanks to our partner:Superpower - https://superpower.com Max's recent essays on peptides: https://maximilianbmartin.substack.com/p/six-peptides-one-signal-washington https://maximilianbmartin.substack.com/p/the-peptide-moment-is-here-enhanced In episode 76 of Hims House, Jonathan Stern hosts Max…
00:54:26
साझा करें
सहेजें
🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem

🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem

Thanks to our partner:Superpower - https://superpower.com In episode 75 of Hims House, Jonathan Stern talks with Dr. Alex Tatem, a board-certified urologist who has worked with peptides for 12 years and paid his own way to Silver Spring, MD, to testify on all 7 peptides before the FDA's Pharmacy C…
00:59:33
साझा करें
सहेजें
अस्वीकरण: इस पृष्ठ पर एम्बेडेड पॉडकास्ट और कलाकृति Jonathan Stern से हैं, जो इसके मालिक की संपत्ति है और Listen Notes, Inc. से संबद्ध या समर्थित नहीं है।
पॉडकास्ट खोज इंजन
आप लोगों, स्थानों या विषयों के आधार पर3,826,057पॉडकास्ट और195,988,214एपिसोड खोजने के लिए हमारी वेबसाइट का उपयोग कर सकते हैं।
ज्ञान में निवेश सबसे अच्छा लाभ देता है, इसलिए मैं पॉडकास्ट सुनता हूँ।  ‐ Benjamin "Llamacorn" Franklin

सुझाव

इस पॉडकास्ट्स को पाने के लिए API का उपयोग करें